Premium
Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy
Author(s) -
Chen Jergin,
Pappas Lisa,
Moeller John H.,
Rankin Jim,
Sharma Pramod K.,
Bentz Brandon G.,
Christine Fang L.,
Hayes John K.,
Shrieve Dennis C.,
Hitchcock Ying J.
Publication year - 2007
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.20528
Subject(s) - brachytherapy , medicine , external beam radiotherapy , radiation therapy , external beam radiation , basal cell , carcinoma , radiology , nuclear medicine
Background. We reviewed the outcomes of oropharyngeal squamous cell carcinoma treated with external beam radiation and interstitial brachytherapy. Methods. Ninety patients with squamous cell carcinoma of the oropharynx were treated with interstitial brachytherapy at the University of Utah between 1984 and 2001. Seventy‐two patients received external beam radiotherapy (EBRT) followed by brachytherapy boost, 11 had surgery followed by EBRT and brachytherapy, 4 had surgery and brachytherapy, and 3 were treated with brachytherapy alone. Median doses for EBRT and brachytherapy were 50 and 24 Gy, respectively. Results. Median follow‐up after brachytherapy was 48.3 months for all patients. Five‐year local control, disease‐free survival, and overall survival were 76%, 61%, and 55%. For T1, T2, T3, and T4, 5‐year local control rates were 83%, 79%, 79%, and 64%, respectively. Severe complications occurred in 13 patients, including 2 treatment‐related deaths. Conclusions. EBRT combined with interstitial brachytherapy provide good local control rates for locally advanced oropharyngeal squamous cell carcinoma. © 2006 Wiley Periodicals, Inc. Head Neck, 2007.